BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16280303)

  • 1. Lymphatic mapping and sentinel lymphonodectomy in recurrent cutaneous squamous cell carcinomas.
    Cecchi R; Buralli L; de Gaudio C
    Eur J Dermatol; 2005; 15(6):478-9. PubMed ID: 16280303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymphonodectomy in non-melanoma skin cancers.
    Cecchi R; Buralli L; De Gaudioc C
    Chir Ital; 2006; 58(3):347-51. PubMed ID: 16845872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of sentinel node biopsy and selective lymphadenectomy in squamous cell carcinoma of the upper limb. Usefulness of sentinel node biopsy to avoid useless lymphadenectomies in high-risk upper limb SCC.
    Cuccia G; Colonna MR; Papalia I; Manasseri B; Romeo M; d'Alcontres FS
    Ann Ital Chir; 2008; 79(1):67-71. PubMed ID: 18572743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy.
    Wagner JD; Evdokimow DZ; Weisberger E; Moore D; Chuang TY; Wenck S; Coleman JJ
    Arch Dermatol; 2004 Jan; 140(1):75-9. PubMed ID: 14732663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined sentinel lymphadenectomy and mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma.
    Weisberg NK; Bertagnolli MM; Becker DS
    J Am Acad Dermatol; 2000 Sep; 43(3):483-8. PubMed ID: 10954660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphatic mapping and sentinel lymph node biopsy in patients with high risk squamous cell carcinoma of the skin].
    Reséndiz-Colosia JA; Valenzuela-Flores AA; Torres-Nuñez G; Valenzuela-Flores AG; Flores-Díaz R; Gallegos-Hernández FJ; Rodríguez-Cuevas SA
    Gac Med Mex; 2007; 143(3):209-14. PubMed ID: 17722449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
    Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
    Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature.
    Renzi C; Caggiati A; Mannooranparampil TJ; Passarelli F; Tartaglione G; Pennasilico GM; Cecconi S; Potenza C; Pasquini P
    Eur J Surg Oncol; 2007 Apr; 33(3):364-9. PubMed ID: 17129703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma.
    Faustina M; Diba R; Ahmadi MA; Esmaeli B
    Ophthalmology; 2004 Oct; 111(10):1930-2. PubMed ID: 15465559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas.
    Kretschmer L; Beckmann I; Thoms KM; Haenssle H; Bertsch HP; Neumann Ch
    Eur J Cancer; 2005 Mar; 41(4):531-8. PubMed ID: 15737557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Squamous cell carcinoma].
    Yamazaki N
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1392-7. PubMed ID: 17033226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
    van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH
    Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining patients with high-risk cutaneous squamous cell carcinoma.
    Veness MJ
    Australas J Dermatol; 2006 Feb; 47(1):28-33. PubMed ID: 16405479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes.
    Heyns CF; Theron PD
    BJU Int; 2008 Aug; 102(3):305-9. PubMed ID: 18410439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive squamous cell carcinoma of the skin: defining a high-risk group.
    Mullen JT; Feng L; Xing Y; Mansfield PF; Gershenwald JE; Lee JE; Ross MI; Cormier JN
    Ann Surg Oncol; 2006 Jul; 13(7):902-9. PubMed ID: 16788750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy: a rational approach for staging T2N0 oral cancer.
    Rigual N; Douglas W; Lamonica D; Wiseman S; Cheney R; Hicks W; Loree T
    Laryngoscope; 2005 Dec; 115(12):2217-20. PubMed ID: 16369170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of sentinel lymph node biopsy in squamous cell carcinoma of the foot: a case report.
    Ozçelik D; Tatlidede S; Hacikerim S; Uğurlu K; Atay M
    J Foot Ankle Surg; 2004; 43(1):60-3. PubMed ID: 14752766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.